The implantable cardioverter defibrillator as a 'bridge to transplant': A viable clinical strategy

American Journal of Cardiology

Volumn 83, Issue 5 B, 1999, Pages

  Schmidinger, Herwig ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVERSION; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATION; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033545686     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)01017-0     Document Type: Conference Paper

References (69)

1. Kriett J.M., Kaye M.P. The Registry of the International Society for Heart and Lung Transplantation eighth official report 1991 . J Heart Lung Transplant. 0:1991;491-498.
2. Balk A.H.M.M., Simoons M.L., Meeter K., Mochtar B., Bal E., Verwey H.F., Weimar W. Too early for cardiac transplantation - the right decision? Eur Heart J. 3:1992;1339-1344.
3. McManus R.P., O'Hair D.P., Beitzinger J.M., Schweiger J., Siegel R., Breen T.J., Olinger G.N. Patients who die awaiting heart transplantation. J Heart Lung Transplant. 2:1993;159-172.
4. Rodeheffer R.J., Naftel D.C., Stevenson L.W., Porter C.B., Young J.B., Miller L.W., Kenzora J.L., Haas G.J., Kirklin J.K., Bourge R.C. Secular trends in cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi institutional study. Cardiac Transplant Research Database Group. Circulation. 4:1996;2883-2889.
5. Effects of enalapril on mortality in severe congestive cardiac failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 16:1987;1429-1435.
6. Miller L.W. Outpatient dobutamine for refractory congestive heart failure advantages, techniques, and results . J Heart Lung Transplant. 0:1991;482-487.
7. Lee H.R., Hershberger R.E., Port J.D., Rasmussen R., Renlund D.G., O'Connell J.B., Gilbert E.M., Mealey P.C., Volkman K., Menlove R., Bristow M.R. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta adrenergic receptors. J Thorac Cardiovasc Surg. 02:1991;246-258.
8. 1 infusion in severe chronic heart failure. Prostaglandins. 3:1997;221-235.
9. 1 - bridge to cardiac transplantation. Technique, dosage, results. Eur Heart J. 8:1997;318-329.
10. Hulsmann M., Stanek B., Frey B., Berger R., Rodler S., Siegel A., Hartter E., Schuller M., Ogris E., Pacher R. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusion in outpatients with severe congestive heart failure. J Heart Lung Transplant. 6:1997;556-562.
11. Sindone A.P., Keogh A.M., Macdonald P.S., McCosker C.J., Kaan A.F. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure safety and cost efficacy . Am Heart J. 34:1997;889-900.
12. Pennington D.G., Swartz M.T. Mechanical circulatory support prior to cardiac transplantation. Semin Thorac Cardiovasc Surg. 2:1990;125-134.
13. Pifarre R., Sullivan H.J., Montoya A., Bakhos M., Grieco J., Foy B.K., Blakeman B., Costanzo-Nordin M.R., Altergott R., Lonchyna V. The use of the Jarvik-7 total artificial heart and the Symbios ventricular assist device as a bridge to transplantation. Surgery. 08:1990;681-685.
14. Oaks T.E., Pae W.E., Miller C.A., Pierce W.S. Combined registry for the clinical use of mechanical ventricular assist pumps and the TAH in conjunction with heart transplantation. Fifth official report 1990. J Heart Transplant. 10:1991;621-625.
15. Liska M.B., Johnson K.E., Emery R.W. Current functional status of Symbion total artificial heart recipients after transplantation. ASAIO Trans. 8:1992;804-807.
16. Parameshwar J., Wallwork J. Left ventricular assist devices current status and future applications . Int J Cardiol. 62:(suppl 1):1997;S23-S27.
17. Noirhomme P., d'Udekem Y., Jacquet L., El Khoury G., Verhelst R., Rubay J., Goenen M., Dion R. Is mechanical circulatory support helpful before cardiac retransplantation? Cardiovasc Surg. 5:1997;584-587.
18. Stevenson L.W., Hamilton M.A., Tillisch I.H., Moriguchi J.D., Kobashigawa J.A., Creaser J.A., Drinkwater D., Laks H. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol. 8:1991;919-925.
19. Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol. 8:1991;545-546.
20. Haverich A., Troster J., Wahlers T., Fieguth H.G., Klein H. The automatic implantable cardioverter defibrillator (AICD) as a bridge to heart transplantation. PACE. 15:1992;701-707.
21. Kubo S.H., Ormaza S.M., Francis G.S., Holmer S.C., Olivari M.T., Bolman R.M. III, Shumway S.J. Trends in patient selection for heart transplantation. J Am Coll Cardiol. 1:1993;975-987.
22. Sweeney M.O., Ruskin J.N., Garan H., McGovern B.A., Guy M.L., Torchiana D.F., Vlahakes G.J., Newell J.B., Semigran M.J., Dec G.W. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation. 2:1995;3273-3281.
23. Trappe H.J., Wenzlaff P. Cardioverter defibrillator therapy as a bridge to heart transplantation. PACE Pacing Clin Electrophysiol. 18:1995;622-631.
24. Narang R., Cleland J.G.F., Erhardt L., Ball S.G., Coats A.J.S., Cowley A.J., Dargie H.J., Hall A.S., Hampton J.R., Poole-Wilson P.A. Mode of death in chronic heart failure. Eur Heart J. 7:1996;1390-1403.
25. Haywood G.A., Rickenbacher P.R., Trindade P.T., Gullestad L., Jiang J.P., Schroeder J.S., Vagelos R., Oyer P., Fowler M.B. Analysis of deaths in patients awaiting transplantation impact on patient selection criteria . Heart. 5:1996;455-462.
26. Pasic M., Loebe M., Hummel M., Grauhan O., Hofmeister J., Weng Y., Hetzer R. Heart transplantation a single center experience . Ann Thorac Surg. 2:1996;1685-1690.
27. Kjekshus J. Arrhythmias and mortality in congestive heart failure. Am J Cardiol. 5:(suppl):1990;42I-48I.
28. Stevenson W.G., Stevenson L.W., Middlekauff H.R., Saxon L.A. Sudden death prevention in patients with advanced ventricular dysfunction. Circulation. 8:1993;2953-2961.
29. Baum R.S., Alvarez H. III, Cobb L.A. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation. 0:1974;1231-1235.
30. Goldstein S., Landis J.R., Leighton R., Ritter G., Vasu C.M., Lantis A., Serokman R. Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease. Circulation. 4:1981;977-984.
31. Myerburg R.J., Kessler K.M., Estes D., Conde C.A., Luceri R.M., Zaman L., Kozlovskis P.L., Castellanos A. Long-term survival after prehospital cardiac arrest analysis of outcome during an 8-year study . Circulation. 0:1984;538-546.
32. Wever E.F., Hauer R.N., Oomen A., Peters R.H., Bakker P.F., Robles de Medina E.O. Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation. 8:1993;1021-1029.
33. Priori S.G., Borggrefe M., Camm A.J., Hauer R.N.W., Klein H., Kuck K.H., Schwartz P.J., Touboul P., Wellens H.J.J. Role of the implantable defibrillator in patients with idiopathic ventricular fibrillation. Data from the UCARE international registry. (Abstr.) PACE Pacing Clin Electrophysiol. 8:1995;799.
34. Brugada J., Brugada R., Brugada P. Right bundle-branch block and ST-segment elevation in leads v1 through v3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation. 7:1998;457-460.
35. Newman D., Sauve M.J., Herre J., Langberg J.J., Lee M.A., Titus C., Franklin J., Scheinmann M.M., Griffin J.C. Survival after implantation of the cardioverter defibrillator. Am J Cardiol. 9:1992;899-903.
36. Powell A., Fuchs T.H., Finkelstein D., Garan H., Cannom D., McGovern B., Kelly E., Vlahakes G., Torchiana D., Ruskin J. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 8:1993;1083-1092.
37. Wever E.F.D., Hauer R.N.W., van Capelle F.J.L., Tijssen J.G.P., Crijns H.J.G.M., Algra A., Wiesfeld A.C.P., Bakker P.F.A., Robles de Medina E.O. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1:1995;2195-2203.
38. Myerburg R.J., Luceri R.M., Thurer R., Cooper D.K., Zaman L., Interian A., Fernandez P., Cox M., Glicksman F., Castellanos A. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 4:1989;508-514.
39. Levine J.H., Mellits E.D., Baumgardner R.A., Veltri E.P., Mower M., Grunwald L., Guarnieri T., Aarons D., Griffith L.S.C. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 4:1991;558-566.
40. Grimm W., Flores B.T., Marchlinski F.E. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy. Circulation. 7:1993;1880-1888.
41. Mehta D., Saksena S., Krol R.B. Survival of implantable cardioverter-defibrillator recipients role of left ventricular function and its relationship to device use . Am Heart J. 24:1992;1608-1614.
42. Anvari A., Stix G., Grabenwoger M., Schneider B., Turel Z., Schmidinger H. Comparison of three cardioverter-defibrillator implantation techniques initial results with transvenous pectoral implantation . PACE Pacing Clin Electrophysiol. 9:1996;1061-1069.
43. Fenelon G., Huvelle E., Brugada P. Initial clinical experience with a new small sized third-generation implantable cardioverter defibrillator: results of a multicenter study. European Ventak Mini Investigator Group. PACE Pacing Clin Electrophysiol. 0:1997;2967-2974.
44. Hoffmann E., Steinbeck G. Experience with pectoral versus abdominal implantation of a small defibrillator. A multicenter comparison in 778 patients: European Jewel Investigators. Eur Heart J. 9:1998;1085-1098.
45. Fogoros R.N. Impact of the implantable defibrillator on mortality the axiom of overall implantable cardioverter-defibrillator survival . Am J Cardiol. 8:1996;57-61.
46. Bolling S.F., Deeb G.M., Morady F., Kadish A., Stirling M.C., deBuitleir M., Kirsh M.M. Automatic internal cardioverter defibrillator a bridge to heart transplantation . J Heart Lung Transplant. 0:1991;562-566.
47. Jeevanandam V., Bielefeld M.R., Auteri J.S., Sanchez J.A., Schenkel F.A., Michler R.E., Smith C.R., Livelli F. Jr, Bigger T., Rose E.A., Spotnitz H.M. The implantable defibrillator an electronic bridge to cardiac transplantation . Circulation. 6:1992;II-276-II-279.
48. Saxon L.A., Wiener I., DeLurgio D.B., Natterson P.D., Laks H., Drinkwater D.C., Stevenson W.G. Implantable defibrillators for high-risk patients with heart failure who are awaiting cardiac transplantation. Am Heart J. 30:1995;501-506.
49. Grimm M., Grimm G., Zuckermann A., Wieselthaler G., Feuerstein M., Daneschvar H., Schmidinger H., Schreiner W., Wolner E., Laufer G. ICD therapy in survivors of sudden cardiac death awaiting heart transplantation. Ann Thorac Surg. 9:1995;916-920.
50. Novick R.J., Menkis A.H., Guiraudon G.M., Sandler D., Pflugfelder P.W., Kostuk W.J., Yee R., Klein G., Powell A.M., McKenzie F.N. Heart transplantation after cardioverter-defibrillator implantation. A case control study. Chest. 03:1993;1710-1714.
51. Fogoros R.N., Elson J.J., Bonnet C.A., Fiedler S.B., Burkholder J.A. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 6:1990;381-386.
52. Kim S.G., Fisher J.D., Choue C.W., Gross J., Roth J., Ferrick K.J., Brodman R., Furman S. Influence of left ventricular function on outcome of patients treated with implantable defibrillators. Circulation. 5:1992;1304-1310.
53. Kim S.G., Maloney J.D., Pinski S.L., Choue C.W., Ferrick K.J., Roth J.A., Gross J., Brodman R., Furman S., Fisher J.D. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center Experience). Am J Cardiol. 2:1993;1263-1267.
54. Mehta D., Saksena S., Krol R.B., John T., Saxena A., Raju R., Kaushik R., Karanam R. Device use patterns and clinical outcome of implantable cardioverter defibrillator patients with moderate and severe impairment of left ventricular function. PACE Pacing Clin Electrophysiol. 16:1993;179-185.
55. Böcker D., Bänsch D., Heinecke A., Weber M., Brunn J., Hammel D., Borggrefe M., Breithardt G., Block M. Potential benefit from ICD therapy in patients with and without heart failure. Circulation. 98:1998;1636-1643.
56. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 85(1:(suppl):1992;I-2-I-10.
57. Packer M. Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failure. Circulation. 85(1:(suppl):1992;I-50-I-56.
58. Singh S.N. Congestive heart failure and arrhythmias therapeutic modalities . J Cardiovasc Electrophysiol. 8:1997;89-97.
59. Bayes de Luna A., Coumel P., Leclercq J.F. Ambulatory sudden cardiac death mechanisms of production of fatal arrhythmia on the basis of data from 157 cases . Am Heart J. 17:1989;151-159.
60. Luu M., Stevenson W.G., Stevenson L.W., Baron K., Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 0:1989;1675-1680.
61. Moss A.J., Hall J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. N Engl J Med. 35:1996;1933-1940.
62. Bigger J.T., Fleiss J.L., Kleiger R., Miller J.P., Rolznitzki L.M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 9:1984;250-258.
63. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
64. Swerdlow C.D., Winkle R.A., Mason J.W. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med. 08:1983;1436-1442.
65. Gomes J.A., Mehta D., Ip J., Winters S.L., Camunas J., Ergin A., Newhouse T.T., Pe E. Predictors of long-term survival in patients with malignant ventricular arrhythmias. Am J Cardiol. 9:1997;1054-1060.
66. Van den Broek S.A.J., van Veldhuisen D.J., de Graeff P.A., Crijns H.J.G.M., van Gilst W.H., Hillege H., Lie K.I. Mode of death in patients with congestive heart failure comparison between possible candidates for heart transplantation and patients with less advanced disease . J Heart Lung Transplant. 2:1993;367-371.
67. Stevenson W.G., Stevenson L.W., Weiss J., Tillisch J.H. Inducible ventricular arrhythmias and sudden death during vasodilator therapy of severe heart failure. Am Heart J. 16:1988;1447-1454.
68. Hammill S.C., Trusty J.M., Wood D.L., Bailey K.R., Vatterott P.J., Osborn M.J., Holmes D.R. Jr, Gersh B.J. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Am J Cardiol. 5:1990;722-728.
69. Lindsay B.D., Osborn J.L., Schechtman K.B., Kenzora J.L., Ambos D., Cain M.E. Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation. Am J Cardiol. 9:1992;619-624.